title: Age-related macular degeneration: an update on treatment.
abstract: Age-related macular degeneration is a chronic disease leading to progressive central vision loss. It is the leading cause of irreversible blindness in the United States, most commonly affecting white Caucasians aged more than 55 years. Typical symptoms include decreased central vision, central scotoma, and metamorphopsia. Patients with acute loss of vision should be promptly referred to an ophthalmologist. New antiangiogenic therapies have significantly improved visual prognosis in these patients.
authors: University of Colorado School of Medicine, Department of Ophthalmology, Denver, CO, USA.
authors: Parin S
authors: PS
authors: Gohel
authors: Naresh
authors: N
authors: Mandava
authors: Jeffrey L
authors: JL
authors: Olson
authors: Vikram D
authors: VD
authors: Durairaj
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000368:Aged; D000375:Aging / Q000502:physiology; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D003131:Combined Modality Therapy; D018450:Disease Progression; D005451:Fluorescein Angiography; D005500:Follow-Up Studies; D006801:Humans; D017075:Laser Coagulation / Q000379:methods; D008268:Macular Degeneration / Q000150:complications / Q000175:diagnosis* / Q000628:therapy*; D008297:Male; D018570:Risk Assessment; D012607:Scotoma / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D016896:Treatment Outcome; D015354:Vision, Low / Q000175:diagnosis / Q000209:etiology
chemical_list: D000305:Adrenal Cortex Hormones; D020533:Angiogenesis Inhibitors